ATTENTION SHAREHOLDERS: Obagi Medical Products, Inc. (OMPI) Board of Directors Investigated by The Young Law Firm for Possibl...
26 Marzo 2013 - 10:28AM
Business Wire
The Young Law Firm is investigating potential claims against the
Board of Directors of Obagi Medical Products, Inc. (“Obagi Medical”
or the “Company”) (NasdaqGS: OMPI) concerning the proposed buyout
of the Company by Valeant Pharmaceuticals International, Inc. The
investigation concerns whether Obagi Medical‘s Board of Directors
obtained fair value for the sale of the Company and whether the
Board has fulfilled its fiduciary duties to Obagi Medical‘s
shareholders in connection with the sale.
Under the terms of the transaction, shareholders will receive
$19.75 for each share of Obagi common stock they own.
Shareholders have rights. If you own shares of Obagi Medical and
would like to learn more about these matters, please contact:
Henry Young Esq.The Young Law FirmToll Free:
(888) 452-7252Email: contact@theyounglf.comor
visit:
www.theyounglf.com/obagi-medical-merger-buyout-shareholder-lawsuit/
The Young Law Firm is a national shareholder litigation firm
located outside of Philadelphia, Pa. We protect individual and
institutional investors in state and federal courts nationwide. For
more information about the firm and class action cases in general,
please visit our website: www.theyounglf.com.
Legal Notice: Pursuant to the laws of certain states of the
United States this press release may be considered attorney
advertising. That The Young Law Firm may have recovered money and
other benefits for shareholders in the past does not mean they will
do so again. Past performance does not guarantee future results. We
are further obliged to tell you that The Young Law Firm may divide
legal fees with other law firms and / or seek referral fees in
connection with the content of this message.
Obagi Medical Products, Inc. (MM) (NASDAQ:OMPI)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Obagi Medical Products, Inc. (MM) (NASDAQ:OMPI)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Obagi Medical Products, Inc. (MM) (NASDAQ): 0 recent articles
Más de The Young Law Firm Artículos de Noticias